Eleva Reaches Industrial Production Scale and Prepares for Cli... - 14 September 2021 10:30

FREIBURG, Germany, Sept. 14, 2021 /PRNewswire-AsiaNet/-- Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases. Eleva has ordered four more state-of-the...

  RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 ... - 13 September 2021 21:58

TEL AVIV, Israel and RALEIGH, N.C., Sept. 13, 2021 /PRNewswire-AsiaNet/ -- - The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care - Number of U.S. si...

  3DMed Diagnostics Donates Medical Supplies to Support COVID-19... - 10 September 2021 21:26

SHANGHAI, Sept. 10, 2021 /PRNewswire-AsiaNet/ -- Shanghai-based biotechnology company, 3DMed Diagnostics, has donated anti-coronavirus medical appliances worth US$218,000 to Cambodia's Ministry of Health to support its campaign against COVID-19. A handover ceremony was held on Friday September 3...

  Cytiva triples single-use consumables capacity in China - 10 September 2021 20:29

SHANGHAI, Sept. 10, 2021 /PRNewswire-AsiaNet/ -- *Three new manufacturing lines were successfully launched in under ten months, with an additional eight new lines planned to launch in Q3 2022. *Sustain and secure the supply chain for customers in China and the broader region. *With the use...

  Winner Medical Celebrates 30th Anniversary with Continued Focu... - 10 September 2021 17:33

SHENZHEN, China, Sept. 10, 2021 /PRNewswire-AsiaNet/ -- Winner Medical Co., Ltd. (300888.SZ), a leading manufacturer of high-quality medical and consumer products, celebrates its 30th anniversary this year alongside the release of its first annual corporate social responsibility report which highlights...

  ABILITY Diabetes Global enrolls thousandth patient: A Cardinal... - 09 September 2021 21:48

TAMPA, Fla., Sept. 9, 2021 /PRNewswire-AsiaNet/ -- ABILITY Diabetes Global [https://www.conceptmedical.com/clinical-program/ability-diabetes-global/] (Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diab...

  Proximie Partners with Teladoc Health to Connect Operating Roo... - 09 September 2021 21:25

BOSTON, September 9, 2021 /PRNewswire-AsiaNet/-- Proximie software to be integrated in Teladoc Health's Solo™ platform ecosystem for hospitals and health systems, enabling an integrated experience for surgeons Proximie, a health technology platform focused on digitizing operating and diagnos...

  Gan & Lee Pharmaceuticals to present data at the 57th Annual E... - 09 September 2021 17:00

BEIJING and BRIDGEWATER, N. J., Sept. 9, 2021 /PRNewswire-AsiaNet/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is excited to present positive data from five abstracts which will be featured as short oral discussions at the 57th Annual European Association for...

  Novavax Initiates Phase 1/2 Clinical Trial of Combination Vacc... - 08 September 2021 23:04

GAITHERSBURG, Md., Sept. 8, 2021 /PRNewswire-AsiaNet/ -- -- First participants enrolled in Phase 1 clinical trial of combination NanoFlu(TM)/NVX–CoV2373 vaccine with Matrix-M(TM) adjuvant -- Phase 1/2 study will evaluate immunogenicity and safety Novavax, Inc. (Nasdaq: NVAX), a biotechnology compa...

  First-of-its-Kind, Global Data Repository for Interstitial Lun... - 08 September 2021 01:00

HOLLAND, Mich., Sept. 7, 2021 /PRNewswire-AsiaNet/ -- -- The highly-anticipated Open Source Imaging Consortium (OSIC) database is driven by global experts in pulmonology, radiology and artificial intelligence, and is the most diverse and largest for rare fibrotic lung diseases The Open Source Imag...